glp-1 gastric emptying Glucagon-Like Peptide-1 Agonists and General Anesthesia: Perioperative Considerations and the Utility of Ultrasound Gastrointestinal Motility Effects of GLP-1

Future research should focus on understanding the long-term metabolic adaptations with these therapies, strategies for sustained weight loss, and long-term safety profile in various age groups

Caution when using GLP-1 RAs in older patients, especially those 75 years old, has been suggested to prevent the risk of sarcopenia

Factors fueling this expansion include rising demand for weight management therapies, advancements in peptide drug innovation, and the focus on chronic disease management and personalized medicine

Ending obesity coverage for GLP-1 obesity drugs could improve the states finances but might also result in health inequities and less comprehensive coverage, the states health and human services agency acknowledged in its September budget request

Based on SURMOUNT-1 data analysis, tirzepatide decreased the 10-year estimated risk of ASCVD for obese or overweight patients

Figure 2 GLP-1 and GLP-1 Analogs In patients with T2D, GLP-1 and GLP-1 analogs were shown to improve cardiovascular-risk profiles, by reducing body fat content, blood pressure, circulating lipids, and inflammatory markers (76)